
MyoKardia (MYOK) Earnings Dates & Reports
MyoKardia (MYOK) Most Recent Earnings
Report DateAug 4, 2020
Period EndingQ2 2020
Est. EPS-$1.46
Actual EPS-$1.27
EarningsBeat
MyoKardia (MYOK) Earnings
View the latest MyoKardia (MYOK) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in MyoKardia (MYOK)
Order type
Buy in
Order amount
Est. shares
0 shares
MyoKardia (MYOK) Earnings per Share (EPS) History
Signup for full accessBrowse free
MyoKardia (MYOK) Latest Earnings
The value each MYOK share was expected to gain vs. the value each share gained.
MyoKardia (MYOK) reported its most recent earnings on Aug 4, 2020 for Q2 2020, posting earnings per share (EPS) of -$1.27. This exceeded analysts' expectations of -$1.46 by 13.01%, marking a Beat.
For comparison, MyoKardia reported EPS of $0 in the same quarter last year.
The company is expected to announce its next earnings report on 11/05/2020, with analysts projecting an EPS of $0.
MyoKardia (MYOK) Earnings History
MyoKardia (MYOK) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the MyoKardia’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| Aug 4, 2020 | — | — | — |
| May 6, 2020 | — | — | — |
| Feb 27, 2020 | — | — | — |
MyoKardia (MYOK) Earnings FAQs
MyoKardia (MYOK) last reported earnings on Aug 4, 2020 for Q2 2020, posting an EPS of -$1.27, which Beat the estimate of -$1.46 by 13.01%.
For Q2 2020, MyoKardia (MYOK) reported an EPS of -$1.27, exceeding analysts' estimate of -$1.46 by 13.01%.
For Q2 2020, MyoKardia (MYOK) Beat expectations with an actual EPS of -$1.27 vs. an estimated EPS of -$1.46.
Following the last earnings report on Aug 4, 2020, MyoKardia (MYOK)'s stock price moved — from — to —.
The next MyoKardia (MYOK) earnings call is scheduled for Nov. 5, 2020, where executives will discuss financial results and outlook.